本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Purple Biotech Ltd.

2.58
-0.1100-4.10%
盤後2.50-0.0748-2.90%16:37 EDT
成交量:1.27萬
成交額:3.32萬
市值:681.91萬
市盈率:-0.58
高:2.74
開:2.74
低:2.50
收:2.69
資料載入中...
2021/02/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/23

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/07/17

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/06

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/05/20

SEC問詢函

CORRESP [Cover] - Correspondence
2020/05/18

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/05/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/03/31

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/23

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/03/23

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/03/11

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/03/10

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/03/10

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/10

SEC問詢函

CORRESP [Cover] - Correspondence
2020/02/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals